RECRUITING

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Next Day Clinic (NDC) is a quality improvement initiative that will be launched and operated by UCLA Health starting July 22, 2024. Its goals are to improve patient care and safety and to maximize cost effectiveness. The way it does this is by identifying patients in the ED who would normally be admitted for low-acuity conditions, and diverting them to a high-acuity clinic the following day called the NDC. This will help decompress the ED and the hospital, and allow for overall higher quality care. The Health System has partnered with UCLA's Healthcare Value Analytics and Solutions \[UVAS\] group which specializes in these types of program evaluations. The analysis conducted by the study team will be used to directly inform NDC operations, scaling, and future plans.

Official Title

Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC)

Quick Facts

Study Start:2024-07-22
Study Completion:2025-11-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06526884

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age or older
  2. * About to be admitted through the ED for one of the NDC diagnoses or a synonym (per Study Protocol document), defined by the presence of a Plan to Admit order or Bed Request order, OR recently admitted under observation or inpatient status for one of the NDC diagnoses.
  3. * Identified as at-risk for an avoidable hospitalization in the ED based on a pre-determined set of lab and vital parameters.
  4. * Insurance that authorizes the patient to follow-up at UCLA Health, or self-pay
  5. * Admitted or being admitted to an internal medicine service
  1. * Heart or lung transplant recipient with concern for graft dysfunction
  2. * Pregnant
  3. * Enrolled in hospice
  4. * Resides in or discharged to a skilled nursing facility/acute rehabilitation facility
  5. * Admitted to a critical care service
  6. * ED deems discharge unsafe due to complex social or medical factors
  7. * Active malignant cancer (per Council of State and Territorial Epidemiologists value set)
  8. * Pulmonary arterial hypertension (per Joint Commission value set)
  9. * Undergoing workup for solid organ transplant
  10. * Interstitial lung disease (including pulmonary fibrosis) (per Higher Level 7 value set)
  11. * Requiring inpatient procedure or surgery defined by the presence of an anesthesia event or operating room encounter.
  12. * The ED deems discharge unsafe due to complex social or medical factors.
  13. * Transferred to an ineligible hospital

Contacts and Locations

Study Contact

Danielle Seiden, MPP
CONTACT
310-267-5147
dseiden@mednet.ucla.edu
Richard Leuchter, MD
CONTACT
310-267-5147
rleuchter@mednet.ucla.edu

Study Locations (Sites)

Ronald Reagan UCLA Medical Center
Los Angeles, California, 90024
United States

Collaborators and Investigators

Sponsor: University of California, Los Angeles

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-07-22
Study Completion Date2025-11-30

Study Record Updates

Study Start Date2024-07-22
Study Completion Date2025-11-30

Terms related to this study

Keywords Provided by Researchers

  • Patient safety
  • Cost effectiveness
  • Avoidable hospitalizations

Additional Relevant MeSH Terms

  • Pneumonia
  • Syncope
  • Congestive Heart Failure
  • Cellulitis
  • Pyelonephritis
  • AKI - Acute Kidney Injury
  • Diabetic Foot Infection
  • Osteomyelitis